purchasing agreement | GenomeWeb

purchasing agreement

Upon entering the agreement, Aspire purchased $1 million in common stock, and may purchase up to $14 million more at Biocept's discretion.

The healthcare IT firm will offer its GeneConnect genetic testing management services to the Children's Hospital Association's 200 members. 

NeoGenomics said it is the first specialized oncology reference laboratory to be a preferred in-network lab option for all Premier members.

NEW YORK (GenomeWeb) – BioFire Diagnostics today said that it has inked a purchasing agreement to provide multi-target molecular diagnostic tests for HealthTrust's nearly 1,400 member healthcare facilities.

NEW YORK (GenomeWeb News) – Privately held Chinese diagnostics services firm iGenomics has purchased 17 of Life Technologies' Ion Proton next-generation sequencing systems and has agreed to add 15 more machines by the end of the year, Life Tech said today.

NEW YORK (GenomeWeb News) – The US President's Emergency Plan for AIDS Relief (PEPFAR) this week announced an additional $11 million to provide Cepheid's Xpert MTB/RIF molecular diagnostic platforms and test cartridges for tuberculosis detection in 14 high-burden countries.

NEW YORK (GenomeWeb News) – One day after saying that its third-quarter revenues would fail to meet expectations, Cepheid said on Thursday that it is acquiring a plastics company and bringing at

NEW YORK (GenomeWeb News) – Illumina today said that it has received a $17 million contract from the US Food and Drug Administration to provide sequencing systems and reagents for food safety testing.

NEW YORK (GenomeWeb News) – Cepheid announced the first agreement to buy down the price of the Xpert MTB/RIF test in order to drive adoption of the technology in resource-poor areas of the world with multi-drug-resistant tuberculosis.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.